Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Celgene Corporation, Clovis Oncology, Genentech, Lilly, Merck & Co., Inc., and Novartis Pharmaceuticals Corporation.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

15th Annual International Lung Cancer Congress®

15th Annual International Lung Cancer Congress®


Agenda


Thursday, July 31, 2014 
7:00 AM Registration and Breakfast  
8:00 AM Welcome and Introductions  
Screening and Staging Chair: David R. Gandara, MD
8:15 AM Keynote: New USPSTF Recommendations on Screening for Lung Cancer James L. Mulshine, MD
8:35 AM Role of Pulmonologists in Optimizing Diagnosis, Staging, and Treatment Choice Ken Y. Yoneda, MD 
8:55 AM Integrated Approach to Staging and Restaging Stephen G. Swisher, MD, FACS
Early-Stage NSCLC Chair: Harvey I. Pass, MD
9:15 AM Current Status of Adjuvant Therapy for NSCLC  Karen Kelly, MD
  Debate: Optimal Approach for High-Risk Patients  
9:35 AM Surgery Harvey I. Pass, MD
9:50 AM SBRT Roy Decker, MD, PhD
10:10 AM Approach to Preoperative Window-of-Opportunity Studies of Novel Therapeutics  Anne Tsao, MD
10:30 AM Case-Based Panel Discussion: Staging and Management of Early-Stage NSCLC Chair: Roy Decker, MD, PhD
10:50 AM Break  
Curative Approaches to Advanced Lung Cancer Chair: Karen Kelly, MD
11:15 AM Keynote: Potential for "Curing" Metastatic NSCLC Paul Bunn, Jr., MD
11:35 AM Potential for "Curing" SCLC
Faculty has not granted permission to post this presentation
Primo Lara, Jr., MD
11:50 AM Question-and-Answer Session
Faculty has not granted permission to post this presentation
 
Workshop 1: Molecular Tumor Board Chair: Roy S. Herbst, MD, PhD
12:00 PM Molecular Testing Tumor Board
Faculty has not granted permission to post this presentation
Juliane M. Jürgensmeier, PhD; Paul Bunn, Jr., MD; Ken Y. Yoneda, MD; James CH Yang, MD, PhD
1:15 PM Break for Lunch   
Workshop 2: The Next Generation of Agents for Lung Cancer Chair: Fred R. Hirsch, MD, PhD
2:50 PM Keynote: TKI Combination Strategies James CH Yang, MD, PhD
3:10 PM Perspective on FGFR inhibitors Paul Bunn, Jr, MD
3:25 PM Strategies for Overcoming KRAS Mutations David R. Gandara, MD
3:40 PM Targeting ROS1 Rearrangements  Sai-Hong Ignatius Ou, MD, PhD
3:55 PM The Future of PI3K inhibitors Jonathan Riess, MD, MS
4:10 PM Break  
4:35 PM Inhibiton of HSP90: Transition Into the Clinic  Suresh Ramalingam, MD
4:50 PM c-Met: Role as a Biomarker and Therapeutic Target in Lung Cancer Karen Kelly, MD
5:05 PM RET Fusions in Lung Cancer  Paul Baas, MD, PhD
5:20 PM PARP Inhibitors: New Insights Everett E. Vokes, MD
5:40 PM Adjourn for the Day  
6:00 PM - 7:00 PM Welcome Reception in the Exhibit Hall  
     
Friday, August 1, 2014
7:00 AM Registration and Breakfast  
7:45 AM Welcome and Introductions  
Combined Modality Therapy for NSCLC Chair: Everett E. Vokes, MD
8:00 AM State of the Art for Multimodality Therapy in Stage III NSCLC Everett E. Vokes, MD 
8:20 AM Surgery in Stage III NSCLC Harvey I. Pass, MD
8:40 AM Optimizing Systemic Regimens and Integrating Targeted Agents Into Combined Modality Therapy Corey J. Langer, MD, FACP
9:00 AM Approaches to Radiation Dose/Schedule and Toxicity in Combined Modality Therapy
Faculty has not granted permission to post this presentation
Walter J. Curran, Jr, MD
9:20 AM Update on the Treatment of Brain Metastases Laurie Gaspar, MD
9:40 AM Case-Based Panel Discussion: Combined Modality Therapy Chair: Everett E. Vokes, MD
10:00 AM Break  
Seventh Annual Addario Foundation Keynote Lecture Introduction: David R. Gandara, MD
10:25 AM Biology of the Immune System in Lung Cancer Roy S. Herbst, MD, PhD
Immunotherapy in NSCLC Chair: Roy S. Herbst, MD, PhD
11:00 AM Response Kinetics and Modified RECIST With Immune Therapies Vassiliki Papadimitrakopoulou, MD
11:20 AM Managing AEs Associated With Immune Blockade Emily Duffield, APRN
11:45 AM Panel Discussion: The Future of Immunotherapy Chair: Roy S. Herbst, MD, PhD
12:05 PM Poster Discussant Jonathan Riess, MD, MS
12:25 PM Break for Lunch   
State-of-the-Art Treatment of NSCLC Chair: Karen Kelly, MD
2:00 PM Current Status of Antiangiogenic Therapy Roy S. Herbst, MD, PhD
2:20 PM Next-Generation EGFR Inhibitors  Fred R. Hirsch, MD, PhD
2:40 PM 1st- and 2nd- Generation ALK Inhibitors
Faculty has not granted permission to post this presentation
Sai-Hong Ignatius Ou, MD, PhD
3:00 PM Acquired Drug Resistance for Oncogene-Driven Cancers Karen Kelly, MD
3:20 PM Break   
Challenges and Opportunities in Lung Cancer and Mesothelioma Chair: Primo Lara, Jr., MD
3:45 PM Maintenance Therapy: Current Status Heather A. Wakelee, MD
4:05 PM Secondline Therapy and Beyond
Faculty has not granted permission to post this presentation
Primo Lara, Jr., MD
4:25 PM Approaches to Mesothelioma Paul Baas, MD, PhD
4:50 PM Case-Based Panel Discussion: Advanced-Stage NSCLC
Faculty has not granted permission to post this presentation
Chair: Primo Lara, Jr., MD
5:10 PM Adjourn for the Day  
6:00 PM - 7:00 PM Get Acquainted Reception in the Exhibit Hall  
     
Saturday, August 2, 2014 
6:00 AM Registration and Breakfast  
7:00 AM Welcome and Introductions  
Cooperative Group Update Chair: Giorgio V. Scagliotti, MD, PhD
7:05 AM Reorganization of the NCI Clinical Trials System David R. Gandara, MD
7:15 AM SWOG David R. Gandara, MD
7:30 AM Europe Giorgio V. Scagliotti, MD, PhD
7:45 AM Asia James CH Yang, MD, PhD
8:00 AM Alliance Everett E. Vokes, MD
8:15 AM NRG Oncology Corey J. Langer, MD, FACP 
8:30 AM ECOG-ACRIN Suresh Ramalingam, MD
8:45 AM Break  
Workshop 3: Multidisciplinary Tumor Board Chairs: Laurie Gaspar, MD and Primo Lara, Jr., MD
9:10 AM Interactive Case-Based Tumor Board  Daniel J. Lieber, MD;
Barbara J. Gitlitz, MD
Personalized Therapy for NSCLC Chair: Philip C. Mack, PhD
10:45 AM A Roadmap for Molecular Testing in 2014: Implications for Therapy Giorgio V. Scagliotti, MD, PhD
11:05 AM Biomarkers for Personalized Lung Cancer Therapy Fred R. Hirsch, MD, PhD
11:25 AM Molecular Staging in the Genomic Era
Faculty has not granted permission to post this presentation
Ignacio I. Wistuba, MD
11:45 AM Break for Lunch  
1:15 PM Incorporating Next-Generation Sequencing Into Clinical Application Philip C. Mack, PhD
1:45 PM Master Protocol Designs for Implementing Personalized Medicine Vassiliki Papadimitrakopoulou, MD
2:05 PM Optimizing Care for Special Populations in Lung Cancer  Paul Baas, MD, PhD
2:30 PM  Closing Remarks and Adjourn  







Become a Member

Forgot Password?
Filter By